-
Uncategorized4 days agoGSK prepares for patent cliff with $2.5B cost-cutting plan
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents...
-
Uncategorized4 days ago
GSK shares rise as $2.5B cost-cutting plan unveiled
As GSK records $2.4 billion in impairment charges for the second quarter, the U.K. pharma has announced a sweeping restructure designed to save about the same...
-
Uncategorized4 days agoSTAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
LONDON — Half a year into taking over the job, GSK CEO Luke Miels on Tuesday laid out his plans to turn the U.K. pharma giant...
-
Uncategorized4 days agoCarterra at centre of US$7bn antibody discovery market
In a report published on July 16 2026, titled Lab-in-the-Loop: AI Rewires Antibody Discovery, Unlocking a US$7 billion LST Opportunity, “Lab-in-the-Loop” (LitL) is described as an...
-
Uncategorized4 days agoSTAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
Regulators at the Food and Drug Administration have reiterated concerns that Replimune does not have adequate data to support an approval of its investigational skin cancer...
-
Uncategorized5 days ago
FDA says Replimune’s melanoma data package is ‘not interpretable,’ setting up tough adcomm
The FDA’s rebuff of Replimune comes a day after the agency similarly called into question the Phase 3 trial for Capricor’s Duchenne muscular dystrophy cell therapy.
-
Uncategorized5 days ago
Eli Lilly tops new biopharma ranking on launch success, development speed
Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella’s inaugural Pipeline-to-Patient Productivity Index, which evaluated 25...
-
Uncategorized5 days ago
Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study
Pemvidutide showed a “highly statistically significant” treatment effect in patients with alcohol use disorder. Altimmune is going up against Eli Lilly and newcomer Baseline Therapeutics in...
-
Uncategorized5 days agoComprehensive Human Vagus Nerve Map Unveiled
Scientists at Northwell Health’s Feinstein Institutes for Medical Research said they have released the world’s first comprehensive human vagus nerve anatomical map. The achievement could change...
-
Uncategorized5 days agoAn eye drug biotech banks $118M and stocks its executive suite
Claris Bio has appointed veteran CEO Stephen Brady to lead advanced development of what it hopes to be the first drug therapy for a blinding condition...
